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Compound  heterozygosity  for hemoglobin  S and  D:
what do  we  need  to  know?Claudia Regina Bonini-Domingos ∗
Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), São José do Rio Preto, SP, BrazilHemoglobinopathies are among the most common heredi-
tary blood diseases worldwide and are considered a public
health problem in some regions. In Brazil, hemoglobin S (Hb
S) has a variable frequency between different regions mainly
due to the ethnic composition of local populations. Due to
the multiethnic characteristics of the Brazilian people, some
regions reﬂect scenarios that allow us to consider the inher-
itance of the symptomatic forms of Hb S, namely sickle cell
disease (SCD) a serious public health problem. These clini-
cally signiﬁcant forms include the homozygous inheritance
of Hb S – sickle cell anemia (Hb SS), inheritance with tha-
lassemia, especially beta thalassemia (Hb S/beta thalassemia)
and compound heterozygotes in which Hb S is inherited in
combination with another hemoglobin variant; the most com-
mon  in Brazil are Hb SC and Hb SD.
The application of accurate laboratory methodologies asso-
ciated to routine techniques such as electrophoresis and high
pressure liquid chromatography (HPLC) along with hemato-
logic information and family data are essential for the correct
identiﬁcation of SCD and, consequently, adequate clinical and
family guidance that can guarantee a promising prognosis.
However, the differentiation between Hb SS and the Hb SD
proﬁle is not possible by simple tests such as electrophoresis
in alkaline pH as, in these conditions, the migrations of the
variants overlap. Additional methods are needed to elucidate
this double heterozygosity. Automated systems such as
capillary electrophoresis, HPLC cation exchange, isoelectric
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systems with variations in the pH are available.1,2
There is certain lack of information about the phenotypic
manifestations of Hb SD and its variations in publications. In
the literature there are some reports of cases of Hb SD with
microcytic and hypochromic anemia, pain crises and clinical
complications.3–5 The presence of associated genetic factors
may modulate the clinical expression and the presence of ele-
vated Hb F levels and the co-inheritance of alpha thalassemia,
for example, should be investigated.6 The correct identiﬁca-
tion of individuals and at least the suggestion of potential
genetic modulators may assist in estimating the response to
treatment using hydroxyurea (HU).7
In our laboratory, 1537 patients with SCD from the south-
eastern region of Brazil were evaluated and 26 (1.69%)
had the Hb SD proﬁle conﬁrmed by molecular analysis
(polymerase chain reaction-restriction fragment length poly-
morphism). Of these, ten (38.46%) individuals were on blood
transfusions and presented microcytosis, hypochromia and
hemolytic indexes that suggested clinically severe disease.
Regarding clinical manifestations, all 26 patients had 2–5
pain crises within one year that not necessarily required
hospitalization but had to be seen in a follow-up service.moglobinas e Genética das Doenc¸as Hematológicas. Rua Cristóvão
azil.
Moreover, the patients suffered from strokes (2), retinopathies
(3), cardiac insufﬁciency (3), acute chest syndrome (6), pul-
monary hypertension (2), cholelithiasis (3), renal failure (3) and
ulcers (2).
 e Terapia Celular. Published by Elsevier Editora Ltda. This is an
mons.org/licenses/by-nc-nd/4.0/).
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The authors of the article “Clinical, hematological and
enetic data in a cohort of children with hemoglobin SD” in
his issue of the Revista Brasileira de Hematologia e Hemoter-
pia (RBHH) show the clinical and hematologic diversity of a
roup of children with this double heterozygosity and high-
ight the importance of the differential diagnosis.8
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